Mr. John McMullen reports

LGC CAPITAL APPOINTS DANIEL LUBIENIETZKY AS VICE PRESIDENT OF CORPORATE DEVELOPMENT TO CONTINUE TO STRENGTHEN ITS STRATEGIC EXECUTIVE TEAM

LGC Capital Ltd. has appointed Daniel Lubienietzky as the company's vice-president of corporate development as of Aug. 7, 2018. The foregoing appointment remains subject to any requisite approval of the TSX Venture Exchange.

In his role as LGC's vice-president of corporate development, Mr. Lubienietzky will work with the executive team in identifying new business opportunities, assist with the integration of various transactions completed by the company, and work with the management of the company and its portfolio companies on strategic planning.

Prior to joining LGC, Mr. Lubienietzky held positions of director of business development and director of sales strategy at TerrAscend Corp, the parent company of Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations. Prior to TerrAscend, Mr. Lubienietzky built and managed a technology resourcing business and held positions in capital markets at TD Securities and the Bank of Canada. Mr. Lubienietzky received his master of business administration at the University of Toronto's Rotman School of Management.

"Daniel is a tremendous addition to our executive team and we are delighted to welcome him to LGC," said John McMullen, chief executive officer of LGC Capital. "He brings with him a depth of experience in business development and operations from inside a licensed producer of cannabis that will help strengthen our strategic management at LGC and our portfolio companies."

"I am very excited to be joining the executive team at LGC Capital," said Mr. Lubienietzky. "LGC, through its portfolio companies, is in the process of building a world-leading, vertically integrated system of interconnected legal cannabis companies that will capture a massive share of the legal global cannabis market."

About LGC Capital Ltd.

LGC Capital is a Canadian incorporated public company listed on the TSX Venture Exchange. LGC's objective is to become a diversified business group with core business divisions that provide shareholders with exposure to a diverse range of businesses, products and services with an emphasis on significant investments in global medical cannabis sector.

We seek Safe Harbor.